SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
RRE Ventures GP II, LLC

(Last) (First) (Middle)
130 EAST 59TH STREET
17TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VOCERA COMMUNICATIONS, INC. [ VCRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/02/2012 C 314,759 A (1) 314,759 I by RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 55,062 A (1) 55,062 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012 C 393,406 A (4) 708,165 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 68,820 A (4) 123,882 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012 C 754,133 A (1) 1,462,298 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 131,831 A (1) 255,713 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012 C 285,577 A (1) 1,747,875 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 49,922 A (1) 305,635 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012 C 78,738 A (1) 1,826,613 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 13,768 A (1) 319,403 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012 C 57,005 A (1) 1,883,618 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012 C 9,972 A (1) 329,375 I By RRE Ventures Fund II, L.P. (3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock (1) 04/02/2012 C 314,759 (1) (1) Common Stock 314,759 (1) 0 I By RRE Ventures II, L.P. (2)
Series A Convertible Preferred Stock (1) 04/02/2012 C 55,062 (1) (1) Common Stock 55,062 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series B Convertible Preferred Stock (4) 04/02/2012 C 214,927 (4) (4) Common Stock 393,406 (4) 0 I By RRE Ventures II, L.P. (2)
Series B Convertible Preferred Stock (4) 04/02/2012 C 37,598 (4) (4) Common Stock 68,820 (4) 0 I By RRE Ventures Fund II, L.P. (3)
Series C Convertible Preferred Stock (1) 04/02/2012 C 754,133 (1) (1) Common Stock 754,133 (1) 0 I By RRE Ventures II, L.P. (2)
Series C Convertible Preferred Stock (1) 04/02/2012 C 131,831 (1) (1) Common Stock 131,831 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series D Convertible Preferred Stock (1) 04/02/2012 C 285,577 (1) (1) Common Stock 285,577 (1) 0 I By RRE Ventures II, L.P. (2)
Series D Convertible Preferred Stock (1) 04/02/2012 C 49,922 (1) (1) Common Stock 49,922 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series E Convertible Preferred Stock (1) 04/02/2012 C 78,738 (1) (1) Common Stock 78,738 (1) 0 I By RRE Ventures II, L.P. (2)
Series E Convertible Preferred Stock (1) 04/02/2012 C 13,768 (1) (1) Common Stock 13,768 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series F Convertible Preferred Stock (1) 04/02/2012 C 57,005 (1) (1) Common Stock 57,005 (1) 0 I By RRE Ventures II, L.P. (2)
Series F Convertible Preferred Stock (1) 04/02/2012 C 9,972 (1) (1) Common Stock 9,972 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series E Convertible Pref St Purchase Warrant (Right to Buy) $6.61 04/02/2012 C 23,621 (5) 10/19/2015 Series E Convertible Preferred Stock (1) 23,621 (1) 0 I By RRE Ventures II, L.P. (2)
Common Stock Purchase Warrant (Right to Buy) $6.61 04/02/2012 C 23,621 (5) 10/19/2015 Common Stock 23,621 (1) 23,621 I By RRE Ventures II, L.P. (2)
Series E Convertible Pref St Purchase Warrant (Right to Buy) $6.61 04/02/2012 C 4,130 (5) 10/19/2015 Series E Convertible Preferred Stock (1) 4,130 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Common Stock Purchase Warrant (Right to Buy) $6.61 04/02/2012 C 4,130 (5) 10/19/2015 Common Stock 4,130 (1) 4,130 I By RRE Ventures Fund II, L.P. (3)
1. Name and Address of Reporting Person*
RRE Ventures GP II, LLC

(Last) (First) (Middle)
130 EAST 59TH STREET
17TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
1. Name and Address of Reporting Person*
RRE Ventures II, LP

(Last) (First) (Middle)
130 EAST 59TH STREET
17TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
1. Name and Address of Reporting Person*
RRE Ventures Fund II, LP

(Last) (First) (Middle)
130 EAST 59TH STREET
17TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
Explanation of Responses:
1. Each share of Series A, Series C, Series D, Series E and Series F Convertible Preferred Stock converted into one share of common stock upon the completion of the Issuer's initial public offering and had no expiration date.
2. RRE Ventures GP II, LLC ("RRE GP") is the sole general partner of RRE Ventures II, L.P. James D. Robinson III, James D. Robinson IV, Stuart J. Ellman, and Andrew L. Zalasin are members of RRE GP and may be deemed to have shared voting and investment control with respect to these shares. Each of RRE GP and Messrs. Robinson III, Robinson IV, Ellman, and Zalasin disclaim beneficial ownership of these shares except to the extent of its or his pecuniary interest therein.
3. RRE GP is the sole general partner of RRE Ventures Fund II, L.P. James D. Robinson III, James D. Robinson IV, Stuart J. Ellman, and Andrew L. Zalasin are members of RRE GP and may be deemed to have shared voting and investment control with respect to these shares. Each of RRE GP and Messrs. Messrs. Robinson III, Robinson IV, Ellman, and Zalasin disclaim beneficial ownership of these shares except to the extent of its or his pecuniary interest therein.
4. Each share of Series B Convertible Preferred Stock converted into 1.8304174 shares of common stock upon the completion of the Issuer's initial public offering and had no expiration date.
5. Immediately exercisable.
Remarks:
/s/ Andrew Zalasin, Member 04/04/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.